期刊文献+

9型腺相关病毒转染乳鼠心肌细胞的可行性及安全性 被引量:4

Feasibility and safety of adeno-associated virus serotype 9 transfection of neonatal rat cardiomyocytes
下载PDF
导出
摘要 背景:9型腺相关病毒对心肌细胞具有更好的靶向转染,是目前研究基因治疗心脏疾病的理想载体。目的:探索9型腺相关病毒体外转染乳鼠心肌细胞的可行性及对乳鼠心肌细胞的毒性评估。方法:分离培养原代乳鼠心肌细胞,以携带荧光蛋白基因的9型腺相关病毒为载体,将分离纯化的乳鼠心肌细胞分为正常培养组、无病毒转染组、病毒转染组。结果与结论:第1周细胞搏动频率及百分率正常培养组和病毒转染组与无病毒转染组比较,差异无显著性意义(P〉0.05),但正常培养组高于病毒转染组(P〈0.05);3周后各组比较,差异无显著性意义(P〉0.05)。经9型腺相关病毒转染的心肌细胞24h开始有表达,4~6d荧光最强,3组细胞72h内不同时间点还原比率均接近于1.0。说明9型腺相关病毒能成功有效地转染乳鼠心肌细胞,对乳鼠心肌细胞无明显毒性作用。 BACKGROUND: Transfection of cardiomyocytes is better achieved using adeno-associated virus serotype 9; adeno-associated virus serotype 9 is an ideal carrier for gene therapy research on heart disease at present. OBJECTIVE: To explore the feasibility of adeno-associated virus serotype 9 transfection of neonatal rat cardiomyocytes and to assess its toxicity on neonatal rat cardiomyocytes. METHODS: The primary cultured neonatal rat cardiomyocytes were isolated and cultured. Based on adding adeno-associated virus serotype 9 carrying enhanced green fluorescent protein or not, the myocardiocytes were divided into three groups: control group, non transfection group and transfection group. RESULTS AND CONCLUSION: There was no significant difference in beat frequency and percentage of pulsating cells among control group, non transfection group and transfection group in the 1st week (P 0.05). However, the beat frequency and percentage of pulsating cells in control group was larger than that in the transfection group (P 0.05). There still was no significant difference in beat frequency and percentage of pulsating cells among the three groups in the 3rd week (P 0.05). Cells in the transfection group began to express myocardial cells in 24 hour after transfection and reached the maximum fluorescence intensity on the 4th to the 6th days. The reduction ratios of three groups were close to 1.0 at different times within 72 hours. These findings indicate that adeno-associated virus serotype 9 can be effectively transfected into neonatal rat cardiomyocytes without significant toxicity.
出处 《中国组织工程研究与临床康复》 CAS CSCD 2012年第2期277-281,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 教育部科学技术研究重点项目(209137) 课题名称:9型腺相关病毒转导PDGF-B基因联合骨髓干细胞移植治疗心肌梗死 新疆维吾尔自治区自然科学基金项目(2009211B20) 课题名称:9型腺相关病毒转导周期素A2基因治疗心肌梗死的实验研究~~
  • 相关文献

参考文献20

  • 1Miake J,Marbán E,Nuss HB.Biological pacemaker created by gene transfer.Nature.2002;419(6903):132-133.
  • 2Thum T,Galuppo P,Wolf C,et al.MicroRNAs in the human heart:a clue to fetal gene reprogramming in heart failure.Circulation.2007;116(3):258-267.
  • 3Mingozzi F,High KA.Therapeutic in vivo gene transfer for genetic disease using AAV:progress and challenges.Nat Rev Genet.2011;12(5):341-355.
  • 4Pacak CA,Mah CS,Thattaliyath BD,et al.ecombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.Circ Res.2006;99(4):e3-9.
  • 5Inagaki K,Fuess S,Storm TA,et al.Robust systemic transduction with AAV9 vectors in mice:efficient global cardiac gene transfer superior to that of AAV8.Mol Ther.2006;14(1):45-53.
  • 6Ueno M,Uchida K,Takaso M,et al.Distribution of bone marrow-derived cells in the fracture callus during plate fixation in a green fluorescent protein-chimeric mouse model.Exp Anim.2011; 60(5):455-462.
  • 7Howard DB,Powers K,Wang Y,et al.Tropism and toxicity of adeno-associated viral vector serotypes 1,2,5,6,7,8,and 9 in rat neurons and glia in vitro.Virology.2008;372(1):24-34.
  • 8Simpson P,Savion S.Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells.Cross-striations,ultrastructure,and chronotropic response to isoproterenol.Circ Res.1982;50(1):101-116.
  • 9徐振平,范雪晖,郑先杰,杨现军,郭志坤.体外培养新生大鼠心肌细胞的形态及其增殖能力[J].中国组织工程研究与临床康复,2007,11(42):8457-8460. 被引量:5
  • 10Huang XP,Sun Z,Miyagi Y,et al.Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.Circulation.2010;122(23):2419-2429.

二级参考文献42

  • 1陈博,胡义珍,曹阳.增强型绿色荧光蛋白在体外培养的牛眼小梁细胞中的表达[J].眼视光学杂志,2006,8(5):278-279. 被引量:3
  • 2DingW, Zhang L, Yan Z, et al. Intracellular trafficking of adeno-associated viral vectors [ J ]. Gene Ther, 2005, 12 ( 11 ) : 873 - 880.
  • 3[nagaki K, Fucss S, Storm TA, et al. Robust systemic transduction with AAV9 vectors in mice : efficient global cardiac gene transfer superior to that of AAVS[J]. Mol Ther, 2006, 14(1) : 45 -53.
  • 4Zincarelli C, Sohys S, Rengo G, et al. Analysis of AAV serotypes 1- 9 mediated gene expression and tropism in mice after systemic injection [J]. Mol Ther, 2008, 16(6) : 1073 -1080.
  • 5Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: Vector toolkit for human gene therapy[ J]. Mol Ther, 2006, 14(3) : 316 - 327.
  • 6Palomeque J, Chemaly ER, del Montel F, et al. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo [ J ]. Gene Ther, 2007, 14 ( 13 ) : 989 - 997.
  • 7Christina A, Cathryn S, Bijoy D, et al. recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo [ J ]. Circu Res, 2006, 99:e3 -e9.
  • 8Miyagi N, Rao VP, Ricci D, et al. Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector [ J]. Heart Lung Transplant, 2008, 27 (5) : 554 - 560.
  • 9Du L, Kido M, Lee DV, et al. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors [ J ]. Mol Ther, 2004, 10(3) : 604 -608.
  • 10Danny C,Christopher C,Matthew D,et al.Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors[J].The Journal of Thoracic and Cardiovascular Surgery,2007,126(3):671-679.

共引文献10

同被引文献30

  • 1Miake J, Marbln E, Nuss HB. Biological pacemaker created by gene transfer. Nature, 2002,419 : 132-133.
  • 2Thum T, Galuppo P, Wolf C, et al. MieroRNAs in the human heart: a clue to fetM gene reprogramming in heart failure. Circulation, 2007, 116 : 258-267.
  • 3Lange S, Heger J, Euler G, et al. Platelet-derived growth factor BB stimulates vaseulogenesis of embryonic stem cell- derived endothelial cells by calcium- mediated generation of reactive oxygen species. Cardiovasc Res ,2009,81 : 159-168.
  • 4Krausgrill B, Vantler M, Burst V, et al. Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuelear and mesenehymal bone marrow cells after transplantation into acute myocardial infarction in rats. Cell Transplant,2009,18 : 847-853.
  • 5Pacak CA, Mah CS, Thattaliyath BD, et al. Recombinant adeno- associated virus serotype 9 lads to preferential cardiac transduetion in vivo. Cire Res, 2006,99 : 3-9.
  • 6Inagaki K, Fuess S, Storm TA, et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther, 2006, 14: 45- 53.
  • 7Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet,2011,12:341-355.
  • 8Wang G, Harold T, Keith R J, et al. Cardioprotective and antiapoptotic effects of heme oxygenase- 1 in the failing heart. Circulation, 2010, 121 : 1912-1925.
  • 9Excoffon KJ, Koerber JT, Dickey DD, et al. Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci USA, 2009, 106:3865-3870.
  • 10Choi KH, Kim JH, Song JE, et al. Phosphoiuositide 3-kinase is a novel target of piceatannol for inhibiting PDGF- BB- induced proliferation and migration in human aortic smooth muscle cells. Cardiovas Res, 2010, 85: 836-844.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部